tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Lu Li, 4 are a BUY (15.38%), 22 are a HOLD (84.62%).
Analyst Lu Li, currently employed at UBS, carries an average stock price target met ratio of 87.62% that have a potential upside of 28.06% achieved within 71 days.
Lu Li’s has documented 51 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MYGN, Myriad Genetics at 08-Sep-2026.
Analyst best performing recommendations are on QDEL (QUIDEL).
The best stock recommendation documented was for QDEL (QUIDEL) at 4/10/2026. The price target of $17 was fulfilled within 4 days with a profit of $3.15 (22.74%) receiving and performance score of 56.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-Dec-2022
$19
$-2.48 (-11.55%)
$15
2 months 4 days ago
(04-Aug-2026)
8/15 (53.33%)
$0.45 (2.43%)
97
Hold Since 05-Aug-2025
$30
$10.04 (50.30%)
1 years 2 months 2 days ago
(05-Aug-2025)
1/1 (100%)
$9.22 (44.37%)
108
Buy Since 18-Nov-2022
$25
$5.04 (25.25%)
$45
1 years 5 months 2 days ago
(05-May-2025)
1/2 (50%)
$5.44 (27.81%)
186
Hold Since 07-Dec-2023
$35
$13.52 (62.94%)
$45
2 years 10 months 1 days ago
(07-Dec-2023)
0/4 (0%)
$8.4 (31.58%)
Buy Since 20-Aug-2020
$125
$103.52 (481.94%)
$141
4 years 8 months 13 days ago
(25-Jan-2022)
4/8 (50%)
$61.5 (96.85%)
70
Which stock is Lu Li most bullish on?
Which stock is Lu Li most reserved on?
What Year was the first public recommendation made by Lu Li?
